Product NDC: | 0496-0716 |
Proprietary Name: | Pramosone |
Non Proprietary Name: | hydrocortisone acetate and pramoxine hydrochloride |
Active Ingredient(s): | 10; 10 mg/g; mg/g & nbsp; hydrocortisone acetate and pramoxine hydrochloride |
Administration Route(s): | TOPICAL |
Dosage Form(s): | CREAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0496-0716 |
Labeler Name: | Ferndale Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA085368 |
Marketing Category: | ANDA |
Start Marketing Date: | 19770131 |
Package NDC: | 0496-0716-33 |
Package Description: | 3 g in 1 TUBE (0496-0716-33) |
NDC Code | 0496-0716-33 |
Proprietary Name | Pramosone |
Package Description | 3 g in 1 TUBE (0496-0716-33) |
Product NDC | 0496-0716 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | hydrocortisone acetate and pramoxine hydrochloride |
Dosage Form Name | CREAM |
Route Name | TOPICAL |
Start Marketing Date | 19770131 |
Marketing Category Name | ANDA |
Labeler Name | Ferndale Laboratories, Inc. |
Substance Name | HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE |
Strength Number | 10; 10 |
Strength Unit | mg/g; mg/g |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |